dr. kade pharma

What dr. kade pharma does

DR. KADE Pharmazeutische Fabrik GmbH is an independent, family-owned German pharmaceutical company headquartered in Berlin, founded in 1886 as a royal court supplier. The company develops, manufactures, and markets OTC and prescription pharmaceutical products across five therapeutic areas: women's health, proctology, gastroenterology and heartburn, children's vitamins, and dermocosmetics. Its branded portfolio includes KadeFungin, KadeFlora, KadeZyklus, Faktu lind, RIOPAN, Multi-Sanostol, and Buer Lecithin (since 1934), with dermocosmetics operated through the wholly owned subsidiary SIRIUS under the SIRIDERMA brand.

The company operates GMP-certified manufacturing at its Berlin-Marienfelde site and is GxP and GDPR compliant. With 300+ employees across two Berlin locations, it maintains a German pharmacy distribution model supported by a dedicated field sales force, while extending internationally through licensing partnerships and contract manufacturing. Pricing for reimbursable products is governed by the German Drug Price Regulation (AMPreisV). Brand and product development is supported by digital professional engagement, including eCME content delivered through the DocCheck platform.

Revenue is not publicly disclosed, and the company has no history of external funding rounds or recent M&A activity, consistent with its status as a privately held, family-controlled enterprise. Recent strategic activity has focused on category extension through new product formats (gummy bears, fizzy lozenges), operating-model separation of SIRIDERMA via SIRIUS, and incremental international expansion via licensing.

Name

dr. kade pharma

Legal name

DR. KADE Pharmazeutische Fabrik GmbH

Website

https://kade.com

Company type

Private

Founded year

1886

Operating status

Operating

Short description

DR. KADE is a Berlin-based, family-owned German pharmaceutical company founded in 1886 that develops, manufactures, and markets OTC and prescription products across women's health, proctology, gastroenterology, children's vitamins, and dermocosmetics, sold through German pharmacies and international licensing.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Women’s Health (OTC Gynecologic) (HLAIADAJ)

akta.pro secondary industry

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

Keywords

• Pharmaceutical manufacturing
• Women's health products
• Proctology treatments
• Children's vitamins
• Dermocosmetics skincare

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices4 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Sale of OTC and prescription pharmaceutical products across five health fields: Women's health, Proctology, Heartburn/Gastroenterology, Children's vitamins, and Dermocosmetics. Products sold through pharmacy channel at regulated prices per German Drug Price Regulation (AMPreisV).
2. Licensing & Contract Manufacturing: Partnerships for licensing products or toll manufacturing for domestic and international partners. Company offers and seeks effective, high-quality health solutions through licensing agreements.

Pricing tiers

Go-to-market motion3 records

Distribution channels2 records

Marketing channels8 records

Core offering

DR. KADE is a Berlin-based pharmaceutical manufacturer that develops, produces and markets OTC and prescription medicines, medical products and dermocosmetic solutions across five health fields — women's health, proctology, gastroenterology (heartburn), children's vitamins and dermocosmetics — sold primarily through German pharmacies and supplemented by licensing and contract manufacturing services for international partners.

Product overview

DR. KADE is an independent family-owned pharmaceutical company based in Berlin, Germany, founded in 1886, specializing in healthcare products for conditions patients typically don't discuss openly ('Gesundheit ohne Scham und Stigma'). The company operates its own manufacturing facilities in Germany and distributes through pharmacies. The product portfolio spans three core therapeutic areas: Women's Health (including KadeFungin® 3 antifungal, KadeFlora® probiotic, and KadeZyklus® menstrual products), Gastroenterology/Proctology (including RIOPAN® antacid and Faktu® lind hemorrhoid treatment), and General Wellness (including Multi-Sanostol® children's vitamins and Buer® Lecithin tonics). The company also maintains licensing and contract manufacturing services for partners.

Differentiator

Problem solved

Functional benefit

Brands

• KadeFungin: Vaginal cream, vaginal tablets, and combination package for fungal infections (Candida albicans) in women's health.
• KadeFlora
• KadeZyklus
• Faktu lind
• RIOPAN
• Multi-Sanostol
• Buer Lecithin
• SIRIDERMA

Products and services

• KadeFungin 3 Antifungal medication containing Clotrimazole for the treatment of vaginal yeast infections (Candida albicans), available as vaginal cream, vaginal tablets and a combination package for adult women purchasing OTC at pharmacies.
• KadeFlora Probiotic vaginal capsules containing Lactiplantibacillus plantarum (strain P 17630) for normalizing vaginal flora after antibiotic treatment and preventing recurring vaginal infections, sold as an OTC product in pharmacies.
• KadeZyklus bei starken Blutungen Traditional herbal medicinal product containing shepherd's purse dry extract (400 mg film-coated tablets) for reducing heavy menstrual bleeding, registered as a traditional herbal medicine and sold OTC in pharmacies.
• KadeZyklus bei Krämpfen Traditional herbal medicinal product containing yarrow dry extract (250 mg film-coated tablets) for symptomatic treatment of mild menstrual cramps, registered as a traditional herbal medicine and sold OTC in pharmacies.
• Faktu lind Hemorrhoid treatment with witch hazel (Hamamelis) extract, available as ointment and suppositories for relieving itching, oozing and burning in early-stage hemorrhoids, sold OTC in pharmacies.
• RIOPAN Antacid medication containing Magaldrate for treating heartburn and acid-related stomach complaints, available as stomach gel and chewable tablets (including mint flavor), sold OTC in pharmacies.
• Multi-Sanostol Multivitamin preparations for preventing combined vitamin deficiency states in children and adolescents, available as syrup (including a sugar-free variant), fizzy lozenges and multivitamin gummy bears, sold OTC in pharmacies.
• Buer Lecithin Traditional herbal medicinal product combining soybean-derived Lecithin with B vitamins, used for relieving exhaustion, fortifying nerves and improving general well-being during periods of fatigue, sold in pharmacies since 1934 as the best-known Lecithin brand in Germany.
• SIRIDERMA Special alkaline dermocosmetic care range marketed through subsidiary SIRIUS, formulated vegan and free from alcohol, fragrances and parabens, intended for customers with sensitive and problematic skin conditions such as atopic dermatitis, psoriasis and very dry skin.
• Licensing and Contract Manufacturing (Lohnherstellung) Service offering that provides licensing of DR. KADE's proven OTC brands and contract (toll) manufacturing of semi-solid pharmaceutical dosage forms (creams, ointments, suppositories) at the GMP-certified Berlin-Marienfelde site to domestic and international pharmaceutical partners.

Segments7 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature2 records

Partnerships

Three partnerships are on record, tiered core and minor.

• DocCheck Community GmbHcoreTechnology or IntegrationDocCheck provides the authentication and access platform for DR. KADE's professional healthcare portal. Healthcare professionals must authenticate via DocCheck to access exclusive eCME content, product information, and professional training materials.
• SIRIUS (Subsidiary)coreStrategic or Co-development PartnerSIRIUS is DR. KADE's subsidiary company developing and manufacturing the SIRIDERMA dermocosmetic product line - special alkaline skincare products for sensitive skin conditions including atopic dermatitis and psoriasis.
• Fürstenberg Institute (EAP Partner)minorImplementation/ SI/ Consulting PartnerEmployee Assistance Programme (EAP) partner providing professional counseling services to employees and managers regarding professional, private, and personal challenges. Services also extend to employees' families.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Almirall S.A. Spanish pharmaceutical company focused on dermatology and OTC skin health products distributed primarily through European pharmacies. Comparable specialty dermatology/OTC positioning similar to DR. KADE's dermocosmetics and women's health niches, at a slightly larger mid-cap scale.
• Pierre Fabre Group: French pharmaceutical and dermo-cosmetic company with strong dermocosmetics franchise and pharmacy-channel distribution in Europe. Comparable to DR. KADE's SIRIDERMA subsidiary and broader OTC pharmacy model, though larger and more internationally diversified.

Broad incumbents

• Kenvue (formerly J&J Consumer Health): Global consumer health company spun out from Johnson & Johnson with strong OTC presence in women's health, GI and skin care. Overlaps with DR. KADE's therapeutic categories but competes at global mass-market scale rather than specialist niche.
• HEXAL (Sandoz/Novartis): One of Germany's largest generics and OTC companies, distributed through pharmacies across multiple therapeutic areas overlapping DR. KADE's portfolio. Operates as a broad incumbent under the Sandoz umbrella rather than a specialist.
• Bayer Consumer Health: Division of Bayer offering a wide OTC portfolio across women's health, GI, dermatology and vitamins distributed in German pharmacies. Overlaps directly with DR. KADE's therapeutic areas but operates as part of a global life-sciences conglomerate at significantly larger scale.
• ratiopharm (Teva): Major German OTC and generics brand owned by Teva, with extensive pharmacy-channel presence in women's health, GI, and dermatology. Comparable pharmacy-channel model and category overlap, though at substantially larger scale and as part of a global generics leader.
• Haleon (formerly GSK Consumer Healthcare): Spun off from GSK as a standalone consumer health company with global OTC brands across oral health, GI, pain relief, and skin health. Overlaps DR. KADE's pharmacy-channel OTC categories but operates globally at much greater scale.
• Sanofi Consumer Healthcare: Global OTC player with broad women's health, GI, and dermatology brands including products distributed in German pharmacies. Comparable OTC categories but at much larger multinational scale with diversified portfolio strategy.

Direct peers

• Dermapharm Holding SE: German mid-cap pharmaceutical company focused on branded OTC and dermatology products, including herbal and botanical medicines, sold primarily through pharmacies. Highly comparable in scale, German pharmacy channel focus, and brand-driven OTC model.
• STADA Arzneimittel AG: German-headquartered, privately-held generics and consumer healthcare company with a broad OTC portfolio across women's health, GI, dermatology and vitamins distributed through pharmacies. Closely comparable mid-sized German OTC pharma with similar pharmacy-channel GTM and family/private ownership profile.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@DrKadePharma
• LinkedInlinkedin.com/company/dr-kade-health-care
• Instagraminstagram.com/dr._kade_health_care

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about dr. kade pharma